12.07.2015 Views

Download Update 11 - Update in Anaesthesia - WFSA

Download Update 11 - Update in Anaesthesia - WFSA

Download Update 11 - Update in Anaesthesia - WFSA

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong> 9excreted the half life <strong>in</strong>creases slowly with deteriorat<strong>in</strong>grenal function until severe nephron loss at which po<strong>in</strong>t thehalf life <strong>in</strong>creases sharply with further reductions <strong>in</strong> renalfunction. Dialysis can only usually replace a small part ofthe excretory capacity of the healthy kidney.Induction agents Their effect is term<strong>in</strong>ated byredistribution. All of these agents are myocardialdepressants and should be adm<strong>in</strong>istered cautiously <strong>in</strong>patients with heart disease.Muscle relaxants Suxamethonium should be avoidedif hyperkalaemia is present.Some non-depolaris<strong>in</strong>g muscle relaxants depend on thekidney for elim<strong>in</strong>ation. Atracurium is the agent of choiceas it undergoes spontaneous Hoffman degradation at bodytemperature.Vecuronium and mivacurium are safe to use <strong>in</strong> renalfailure as only small percentages are excreted renally.Gallam<strong>in</strong>e should be avoided and pancuronium,alcuronium, pipecuronium, curare and doxacuriumshould be used with caution. Potentiation of neuromuscularblockade may occur <strong>in</strong> the presence of a metabolicacidosis, hypokalaemia, hypermagnesaemia, orhypocalcaemia and with medications such asam<strong>in</strong>oglycosides. Monitor neuromuscular blockadewhenever possible.Opioids Morph<strong>in</strong>e is metabolised <strong>in</strong> the liver to morph<strong>in</strong>e-6-glucuronide which has about half the sedative effect ofmorph<strong>in</strong>e with a markedly prolonged half life. Pethid<strong>in</strong>e ispartially metabolised to norpethid<strong>in</strong>e which is less analgesicand has excitatory and convulsant properties. Both ofthese metabolites may accumulate <strong>in</strong> renal failure afterrepeated doses or with <strong>in</strong>fusions. Standard <strong>in</strong>traoperativeuse will not usually cause problems. When available,morph<strong>in</strong>e is preferable to pethid<strong>in</strong>e.Fentanyl and alfentanil can be used as normal.Benzodiazep<strong>in</strong>es can be used <strong>in</strong> renal failure.Inhalational agents There is decreased elim<strong>in</strong>ation ofthe fluoride ions which are significant metabolites ofenflurane, sevoflurane and methoxyflurane which canworsen renal function, so these <strong>in</strong>halational agents shouldbe avoided especially if used at low flows.Non steroidal anti <strong>in</strong>flammatory agents (NSAIDS)should be avoided as all decrease renal blood flow andmay precipitate complete renal failure.Conduct of <strong>Anaesthesia</strong>Premedication Oral sedatives such as diazepam ortemazepam may be used. H 2antagonists or non particulateantacids (e.g. sodium citrate) should be given ifoesophageal reflux is a problem.<strong>Anaesthesia</strong> Venous access may be difficult. If futurehaemodialysis is planned it is important to preserve AVfistulas and potential fistula sites. Forearm and antecubitalve<strong>in</strong>s should be avoided if possible <strong>in</strong> these patients.Full monitor<strong>in</strong>g must be established prior to <strong>in</strong>duction ofanaesthesia, with special attention be<strong>in</strong>g paid to the ECGand blood pressure. The patient should be kept welloxygenated and haemodynamically stable. Hypovolaemiaand hypotension worsen renal function therefore bloodand other fluid losses should be carefully replaced. Ifpossible the shorter act<strong>in</strong>g sedative agents should be used.If sp<strong>in</strong>al or epidural anaesthesia is be<strong>in</strong>g performed fluidpreload<strong>in</strong>g should be kept to a m<strong>in</strong>imum andvasoconstrictors used to ma<strong>in</strong>ta<strong>in</strong> the blood pressure.Otherwise postoperative fluid overload may necessitatedialysis.Postoperatively Postoperative fluid balance must bemeticulous and prompt action taken to limit vomit<strong>in</strong>g andreplace any fluids lost. Some patients may requirehaemodialysis for fluid overload postoperatively but thisshould be delayed if possible as the patient will have to behepar<strong>in</strong>ised. Some patients may become drowsy onrelatively low doses of analgesics.Oxygen (2-3 litres/m<strong>in</strong>ute nasally or 3-4 litres/m<strong>in</strong>ute viaface mask) should be adm<strong>in</strong>istered for 48 hours after majorabdom<strong>in</strong>al or thoracic surgery and 24 hours after<strong>in</strong>termediate surgery.PREVENTING ACUTE RENAL FAILUREPreviously healthy patients most at risk of develop<strong>in</strong>g acuterenal tubular necrosis are those with massive haemorrhage,multiple trauma, sepsis, extensive burns and crush <strong>in</strong>juries,especially if they already have some degree of renalimpairment. Renal failure is diagnosed when ur<strong>in</strong>e outputis persistently

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!